Loading viewer...
investor_presentation
Format: PDF investor_presentation
BriaCell Therapeutics presents an overview of its cancer immunotherapy pipeline and clinical development strategy. The presentation outlines the company's capitalization structure, including Nasdaq and TSXV listings, cash position of approximately $60M, and market capitalization of $87.6M as of June 2021. Forward-looking statements address development timelines, regulatory pathways, and capital requirements for advancing its therapeutic programs.
investor_presentation
17 Pages
investor_presentation
53 Pages
Hindustan Petroleum Corporation Limited
Karyopharm Therapeutics Corporate Update November 2016
investor_presentationinvestor_presentation
23 Pages
Karyopharm Therapeutics Inc.
investor_presentation
ArQule